Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma

Acta Oncologica

Volumn 46, Issue 8, 2007, Pages 1090-1096

  Wei, Ye Sheng ^a   Lan, Yan ^a   Liu, Yun Guang ^a   Tang, Hui ^b   Tang, Ren Guang ^a   Wang, Jian Chu ^a  

^a YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 18;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; DNA SEQUENCE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; STATISTICAL SIGNIFICANCE;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SEVERITY OF ILLNESS INDEX;

EID: 35848967027     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860701373595     Document Type: Article

References (31)

1. Blot WJ. Esophageal cancer trends and risk factors. Semin Oncol 1994;21:403-10.
2. Van Rensburg SJ. Epidemiologic and dietary evidence for a specific nutritional predisposition to esophageal cancer. J Natl Cancer Inst 1981;67:243-51.
3. Gustavsson P, Evanoff B, Hogstedt C. Increased risk of esophageal cancer among workers exposed to combustion products. Arch Environ Health 1993;48:243-5.
4. Zhang J, Jin X, Fang S, Wang R, Li Y, Wang N, et al. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and nonsmall cell lung carcinoma. Carcinogenesis 2005;26:1748-53.
5. Li Y, Zhang X, Huang G, Miao X, Guo L, Lin D, Lu SH. Identification of a novel polymorphism Arg290Gln of esophageal cancer related gene 1 (ECRG1) and its related risk to esophageal squamous cell carcinoma. Carcinogenesis 2006;27:798-802.
6. Zhang J, Li Y, Wang R, Wen D, Sarbia M, Kuang G, et al. Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. Int J Cancer 2003;105:281-4.
7. Liebau C, Baltzer AW, Schmidt S, Roesel C, Karreman C, Prisack JB, et al. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma. Anticancer Res 2002;22:931-6.
8. Moore MB, Kurago ZB, Fullenkamp CA, Lutz CT. Squamous cell carcinoma cells differentially stimulate NK cell effector functions: The role of IL-18. Cancer Immunol Immunother 2003;52:107-15.
9. Chia CS, Ban K, Ithnin H, Singh H, Krishnan R, Mokhtar S, et al. Expression of interleukin-18, interferon-gamma and interleukin-10 in hepatocellular carcinoma. Immunol Lett 2002;84:163-72.
10. Tsuboi K, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Manda R, et al. Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma. Cancer Lett 2004;205:207-14.
11. Xia D, Li F, Xiang J. Engineered fusion hybrid vaccine of IL-18 gene-modified tumor cells and dendritic cells induces enhanced antitumor immunity. Cancer Biother Radiopharm 2004;19:322-30.
12. Han MY, Zheng S, Yu JM, Peng JP, Guo QS, Wang JL. Study on interleukin-18 gene transfer into human breast cancer cells to prevent tumorigenicity. J Zhejiang Univ Sci 2004;5:472-6.
13. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: A possible role of polymorphisms in expression regulation. J Neuroimmunol 2001;112:146-52.
14. Imboden M, Nicod L, Nieters A, Glaus E, Matyas G, Bircher AJ, et al. The common G-allele of interleukin-18 single-nucleotide polymorphism is a genetic risk factor for atopic asthma. The SAPALDIA Cohort Study. Clin Exp Allergy 2006;36:211-8.
15. Jang WC, Park SB, Nam YH, Lee SS, Kim JW, Chang IS, et al. Interleukin-18 gene polymorphisms in Korean patients with Behcet's disease. Clin Exp Rheumatol 2005;23:S59-S63.
16. Tiret L, Godefroy T, Lubos E, Nicaud V, Tregouet DA, Barbaux S, et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005;112:643-50.
17. Gracie JA, Koyama N, Murdoch J, Field M, McGarry F, Crilly A, et al. Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients. Genes Immun 2005;6:211-6.
18. Pratesi C, Bortolin MT, Bidoli E, Tedeschi R, Vaccher E, Dolcetti R, et al. Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 2006;55:23-30.
19. Bushley AW, Ferrell R, McDuffie K, Terada KY, Carney ME, Thompson PJ, et al. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol Oncol 2004;95:672-9.
20. Ide A, Kawasaki E, Abiru N, Sun F, Kobayashi M, Fukushima T, et al. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J Autoimmun 2004;22:73-8.
21. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97-8.
22. Stephens M, Smith MJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
23. Sivalingam SP, Yoon KH, Koh DR, Fong KY. Singlenucleotide polymorphisms of the interleukin-18 gene promoter region in rheumatoid arthritis patients: Protective effect of AA genotype. Tissue Antigens 2003;62:498-504.
24. Novota P, Kolostova K, Pinterova D, Novak J, Treslova L, Andel M, et al. Interleukin IL-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults. Immunol Lett 2005;96:247-51.
25. Rueda B, Gonzalez-Gay MA, Mataran L, Lopez-Nevot MA, Martin J. Interleukin-18 promoter polymorphisms are not relevant in rheumatoid arthritis. Tissue Antigens. 2005;65:544-8.
26. Cardoso SM, DeFor TE, Tilley LA, Bidwell JL, Weisdorf DJ, MacMillan ML. Patient interleukin-18 GCG haplotype associates with improved survival and decreased transplant-related mortality after unrelated-donor bone marrow transplantation. Br J Haematol 2004;126:704-10.
27. Gracie JA, Koyama N, Murdoch J, Field M, McGarry F, Crilly A, et al. Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients. Genes Immun 2005;6:211-6.
28. Charles AD. Interleukin-18. Methods 1999;19:121-32.
29. Nouh MA, Eissa SA, Zaki SA, El-Maghraby SM, Kadry DY. Importance of Serum IL-18 and RANTES as markers for breast carcinoma progression. J Egypt Natl Canc Inst 2005;17:51-5.
30. Thong-Ngam D, Tangkijvanich P, Lerknimitr R, Mahachai V, Theamboonlers A, Poovorawan Y. Diagnostic role of serum interleukin-18 in gastric cancer patients. World J Gastroenterol 2006;12:4473-7.
31. Takagawa T, Tamura K, Takeda N, Tomita T, Ohda Y, Fukunaga K, et al. Association between IL-18 gene promoter polymorphisms and inflammatory bowel disease in a Japanese population. Inflamm Bowel Dis 2005;11:1038-43.